What still needs to be achieved in the clinical situation? VTE Symposium – sharing good practice 21 st September 2010 Dr Tamara Everington.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Preventing Hospital Associated Thrombosis: measuring outcomes Roopen Arya King’s College Hospital VTE Prevention NHS Showcase 16 September 2013.
Undertaking root cause analysis Dr. Peter Woodhouse, Chair, Thrombosis & Thromboprophylaxis Committee, Norfolk & Norwich University Hospital.
The Thrombosis Committee: an Instrument for Governance & Change
Working together to achieve nursing excellence in VTE Katrina Glaister Clinical Governance Facilitator (VTE Project Nurse) Salisbury NHS Foundation Trust.
Jeff Reece, RN, MSN, MBA Chief Executive Office Chesterfield General Hospital.
The National Audit of Falls and Bone Health in Older People [Speaker’s name and designation] On behalf of the Clinical Effectiveness and Evaluation Unit,
VTE Assessments in Acute General Medicine at the John Radcliffe Hospital Srimathy Vijayan CMT 1, John Radcliffe Hospital Learning To Make a Difference.
Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
Anne Blumgart Principal Pharmacist DUE Improvement Science Professional Development Program Venous Thromboembolism (VTE) Prevention in Ward 9.
Beverley Hunt Simon Noble Hospital Acquired Venous Thromboembolism.
QAH HospitalPortsmouth Hospitals NHS Trust Venous Thromboembolism Patient Safety Study Day Simon Freathy.
VTE Prophylaxis Updates and Clarification to the Process.
Venous ThromboEmbolism
DVT/VTE Nursing Protocol (Deep Vein Thrombosis) (Venous Thromboembolism) Presented by Maribeth Desiongco MA, RN-BC 2008.
ITU Discharge Audit Mark Smithies – Consultant Shabana Anwar – Advanced Trainee Brian Johnston – AFP1 May 2013.
Medication Safety Standard 4 Part 3 – Documentation of Patient Information, Continuity of Medication Management Margaret Duguid, Pharmaceutical Advisor.
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
Hospital acquired VTE Alert system Caroline Baglin Thrombophilia CNS.
Management of Adults with Diabetes undergoing Surgery and Elective Procedures UHL Guideline – April 2013 The aim of the guideline is to improve standards.
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
IMPLEMENTING GUIDELINES AND REDUCING PATIENT RISK OF VENOUS THROMBOEMBOLISM IN A LARGE UK TEACHING HOSPITAL Sharron Millen, Head of Clinical Pharmacy and.
Venous Thromboembolism
A Regional Approach to Improvement Julie Branter Associate Director for Clinical Governance and Patient Safety 21 September 2010 South West Strategic Health.
Peter Davies Senior Pharmacist.  Venous thromboembolic prevention is a DH patient safety priority  NICE clinical guideline venous thromboembolism reducing.
‘Active Risk Management at Rotherham’ Rotherham NHS FT QUEST presentation 24th June 2011 Dr Trisha Bain.
Preventing Hospital Acquired Thrombosis Simon Noble Peggy Edwards.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
Scottish Patient Safety Programme – Pharmacist Engagement Gordon Thomson Arlene Coulson Shadi Botros.
End of Life Care At the West Suffolk Hospital
VTE Venous ThromboEmbolism. VTE – aims of this module To define the terms associated with VTE and offer maximum care to treat patients. To define the.
VTE Prevention In Action Interactive Case Scenarios.
VTE prevention and anticoagulation practice VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis Nurse RCHT.
Is the 7 day service the future of pharmacy in acute medicine? David Young.
A Strategy for Auditing VTE Prevention Rebecca Brown Carol Law
The Anticoagulation Service at Salisbury District Hospital Nic McQuaid And Rachel Woodford Anticoagulation Nurse Practitioners.
Anticoagulants Reducing the risk Amanda Powell & Sue Wooller May 2014.
Mandatory Training: VTE prevention and anticoagulation practice Mandatory Training: VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis.
Quality and Patient Safety Council May 27, 2014 Presented By Susan M. Blackhurst BS, RN & Eric Jean BSN, RN, CCRN.
Orthopaedic Thromboprophylaxis: Experience from Derriford Hospital
Is the 7 day service the future of pharmacy in acute medicine? David Young.
Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing June 2012 NICE clinical guideline.
Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital
Adult Community Nursing and Primary Care nursing working together to meet patients’ needs closer to home. Spotlight on the MY Integrated Care Team.
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
‘Preventing and treating blood clots’ The South Tees Anticoagulation Team 1.
Quality Accounts 2010/11: Looking back, looking forward Dr Patricia Bain Director of Quality & Standards 14 th September 2011.
JUST GIVE IT: a 2 phase study to audit the Immediate Management of Patients with Proven or Suspected Neutropenic Sepsis by Ally Gruber Acute Oncology Clinical.
The Royal College of Emergency Medicine VTE Risk in Lower Limb Immobilisation in Plaster Cast Clinical Audit National findings The Royal College.
Insert name of presentation on Master Slide Hospital Acquired Thrombosis Simon Noble and Mike Fealey.
Dr N Mudondo (FY2) Mr C Chatzdimitriou (SpR Breast Surgery) Mr M Haider (SpR Breast Surgery)
VTE prophylaxis Sharif-Kashani,B.MD SBMU Preventing VTE Over 12 million people in the United States are at risk of VTE due to hospitalization for major.
Anthony Williams, FY2 Jo McCarthy, FY2 Charlotte Davies, FY2
VTE Risk Assessment & Prophylaxis in OB
Venous Thromboembolism Prophylaxis (VTE)
Powys teaching Health Board
2.13 Copyright UKCS #
Reducing Mortality and Harm
The Burden of Hospital-Associated Venous Thromboembolism
Preventing VTE in hospitalised patients
ADAS Anticoagulant Dosing and Advisory Service
Global Burden of VTE. Preventing Thrombosis During and Post-Hospitalization: New Paradigms in Clinical Care.
VTE in Cancer.
Extraordinary Cases of VTE Prevention in Patients With Cancer
Systems Thinking for Everyday Work (STEW) Worksheet
Cancer-Associated Thrombosis
An Unmet Need.
Cardiff and Vale UHB Dr Graham Shortland
Presentation transcript:

What still needs to be achieved in the clinical situation? VTE Symposium – sharing good practice 21 st September 2010 Dr Tamara Everington

1. Doctor 2. Nurse 3. Pharmacist 4. Risk Manager 5. Executive 6. Other What is your background?

NICE Quality Standard 1  “All patients, on admission, receive an assessment of VTE and bleeding risk”

How do we crack the last 10%?

Which 1 of these do you think is most likely to increase compliance with VTE risk assessment? 1. CQUINS targets 2. Executive Drivers 3. Better staff education 4. Electronic Systems 5. Productive Wards

NICE Quality Standard 2  “Patients are re-assessed within 24 hours of admission for risk of VTE and bleeding”

How should you document repeat VTE RA at 24 hours? 1. Repeat the initial VTE RA document 2. Document in the clinical pathway (PTWR) 3. Pharmacy check 4. Nurse check 5. Other

NICE Quality Standard 3  “Patients assessed to be at risk of VTE are offered VTE prophylaxis in accordance with NICE guidance”

Which groups would you adjust thromboprophylaxis dose in? 1. Renal impairment 2. Obesity 3. Cancer patients with cachexia 4. Recurrent “fallers” 5. All of the above 6. None of the above

Which day cases do you plan to risk assess? 1. Day surgery under GA 2. Day surgery under LA 3. Fracture clinic 4. Chemotherapy patients 5. Medical day cases 6. 1,(2), 3 & 4 7. All of the above

In theory we could reduce secondary VTE by 65%?

How will you pick up secondary VTE? 1. Via anticoagulant referrals 2. Via radiology reports of VTE 3. Via clinical coding 4. Via death certificates 5. Via the Coroner 6. Combination of the above?

NICE Quality Standards 4 & 5  “Patients / carers are offered verbal and written information on VTE prevention at time of admission…. & as part of the discharge process”

If only!!! Simples!!!!

What information is most likely to work? 1. Written information 2. Visual information 3. Face-to-face explanation 4. A mixture of the above

NICE Quality Standard 6  “Patients provided with anti-embolism stockings have them fitted and monitored in accordance with NICE guidance”

Which of the following have you seen on patients? 1. Which of the following have you seen on patients? 2. Stockings causing a ‘tourniquet’ effect 3. Damaged legs from stockings 4. Soiled stockings 5. All of the above 6. “I wish you hadn’t asked that question”

NICE Quality Standard 7  “Patients receive extended postoperative VTE prophylaxis in accordance with NICE guidance”

A 65 year old woman with a history of VTE has incurable ovarian cancer with reduced mobility which can be controlled with indefinite chemotherapy. How long would you continue thromboprophylaxis? 1. Not at all 2. Aspirin only 3. For 28 days following surgery 4. Indefinitely

Root cause analysis – How do we do this?

Which method of RCA do you think will be most effective? 1. RCA by the Thrombosis Committee 2. RCA by the VTE nurse 3. RCA by Clinical risk 4. RCA by Clinical teams